Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury
Clinical trial NCT02352649 · UNKNOWN
Trial details
- NCT number
- NCT02352649
- Sponsor
- Artgen Biotech
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-03-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.